Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Gastroenterol Clin North Am. 2015 Apr 9;44(2):203–231. doi: 10.1016/j.gtc.2015.02.001

Table 1.

Studies Examining the Prevalence of Barrett’s Esophagus

AUTHOR(S) YEAR COUNTRY SETTING,
DESIGN
STUDY
SAMPLE
SAMPLE
SIZE
%
MALE
AVG
AGE
(Y)
HISTOLOGIC
CONFIRMATION
?
NO.
WITH BE
(%)
NO.
WITH
LSBE
(%)
NO.
WITH
SSBE
(%)
GERSON ET AL156 2002 U.S. Single VA
Center, not
population-
based
Individuals
without GERD
sx receiving
sigmoidoscopy
for CRC
screening,
110 92.0 61.0 Yes 27
(24.5%)
19
(17.3%)
8
(7.3%)

REX ET AL14 2003 U.S. Multicenter,
not
population-
based
Individuals
receiving
colonoscopy,
no GI sx other
than reflux or
regurgitation
961 59.5 59.0 Yes 65
(6.8%)a
12
(1.2%)
53
(5.5%)

RONKAINEN ET AL13 2005 U.S. Population-
based sample
from 2
Swedish
communities
Random
sample of
census-based
registry
1000 49.0 53.6 Yes 16
(1.6%)b
5
(0.5%)
11
(1.1%)

WARD ET AL157 2006 U.S. Single
tertiary-care
center, not
population-
based
Individuals
referred for
screening
colonoscopy
300 53.7 61.0 Yes 50
(16.7%)c
4
(1.3%)
46
(15.3%)

ZAGARI ET AL 15 2008 Italy Population-
based sample
from 2 Italian
communities
Individuals
remaining
from original
sample who
elected to
participate
1033 51.1 59.7 Yes 13
(1.3%)d
2
(0.2%)
11
(1.1%)

ZOU ET AL158 2011 China Population-
based sample
from 2
Chinese areas
Individuals
remaining
from random
sample who
elected to
participate
1030 42.3 NR No 19
(1.8%)e
NR NR
a

Prevalence among those with GERD symptoms was 8.3%

b

Prevalence among those with GERD symptoms was 2.3%

c

Prevalence among those with GERD symptoms was 19.8%

d

Prevalence among those with GERD symptoms was 1.5%

e

Prevalence among those with GERD symptoms was 2.1%

Data from Refs 1315,156158.